Skip to content
Screener

Total Revenue at other companies

Eli Lilly logo
Eli LillyLLY
$22.97B+47.7%
AbbVie logo
AbbVieABBV
$16.99B+10.2%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$12.49M+32.4%
Establishment Labs logo
Establishment LabsESTA
$67.54M+31.7%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$2.52B+11.7%

Segments

By segment

See full
Reportable Segment$42.9M-2.5%

Other financials

Income statement

See full
Gross profit$26.3M-1.8%
Operating income-$29.0K-104%
Net income-$1.1M-88.2%
EPS (diluted)-$0.02-100%

Balance sheet

See full
Cash & equivalents$18.8M+130%
Total debt$70.5M-17.4%
Total equity$104.8M+16.4%
Total assets$193.3M-2.6%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$228.0K-14.0%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$194M-50.2%
Enterprise value$245.64M-47.4%
P/S1.3×-1.1×

Profitability

See full
Gross margin59.7%+0.6pp
Operating margin-8.4%+14.7pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.3×
Current ratio0.8×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: AirSculpt Technologies, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 9:37 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001870940-26-000038
(in $000s, except for shares and per share figures)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$42,900$44,012$82,289$83,383
Operating expenses:
Cost of service (exclusive of depreciation and amortization)16,56717,20132,15533,151
Selling, general and administrative23,42122,67146,00344,439
Depreciation and amortization2,9413,2465,9626,488
Loss on impairment of long-lived assets108108
Total operating expenses42,92943,22684,12084,186
(Loss)/income from operations(29)786(1,831)(803)

Item 1. Financial Statements

FAQ

What is AirSculpt Technologies, Inc.'s total revenue?
AirSculpt Technologies, Inc. (AIRS) reported total revenue of $42.9M in Q2 2026.
How has AirSculpt Technologies, Inc.'s total revenue changed year-over-year?
AirSculpt Technologies, Inc.'s total revenue decreased by 2.5% year-over-year, from $44.01M to $42.9M.
What is the long-term trend for AirSculpt Technologies, Inc.'s total revenue?
Over 4 years (2021 to 2025), AirSculpt Technologies, Inc.'s total revenue has grown at a 3.3% compound annual growth rate (CAGR), from $133.32M to $151.82M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about AirSculpt Technologies, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude